Washington Insurance Chief Urges Medicare Insurers to Maintain Agent Commissions

During the Medicare Open Enrollment period, Washington state Insurance Commissioner Patty Kuderer addressed concerns over the discontinuation of commission payments by insurers to agents assisting beneficiaries in choosing Medicare plans. Kuderer urged insurance companies, particularly Humana and UnitedHealthcare, to continue paying commissions to independent producers, brokers, and agents who help seniors and people with disabilities navigate complex Medicare plan selections. The commissioner highlighted that eliminating commissions could reduce the incentive for producers to market these plans effectively, potentially steering sales towards products favored by insurers rather than those suitable for consumers. Kuderer emphasized the significant role of licensed independent producers who invest substantial time, such as reviewing provider networks and prescription drug formularies, to ensure beneficiaries maintain access to preferred healthcare providers and affordable medications. She stressed that producers are ethically and legally obligated to prioritize the best interests of Medicare beneficiaries by assisting them in finding and enrolling in plans that meet their needs. Although state law does not empower the commissioner to prohibit insurers from discontinuing commissions, Kuderer sought to raise awareness about the negative consumer and market impacts of this practice. Kuderer expressed concern that manipulating the Medicare Advantage and Prescription Drug Plan markets in ways that harm beneficiaries is unethical and urged insurers to prioritize prescription drug coverage quality, provider access, and plan affordability. Medicare Open Enrollment in Washington runs through December 7, 2025, with plan changes becoming effective January 1, 2026. The actions and policies related to commission payments during this period carry broader implications for insurance market dynamics, consumer choice, and regulatory oversight. Kuderer’s stance underscores ongoing challenges in balancing insurer business models with the need for comprehensive consumer support during complex healthcare plan selections.